199 related articles for article (PubMed ID: 21460389)
1. Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry.
Van Dyke MV; Martyny JW; Mroz MM; Silveira LJ; Strand M; Cragle DL; Tankersley WG; Wells SM; Newman LS; Maier LA
Occup Environ Med; 2011 Nov; 68(11):842-8. PubMed ID: 21460389
[TBL] [Abstract][Full Text] [Related]
2. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.
Van Dyke MV; Martyny JW; Mroz MM; Silveira LJ; Strand M; Fingerlin TE; Sato H; Newman LS; Maier LA
Am J Respir Crit Care Med; 2011 Jun; 183(12):1680-8. PubMed ID: 21471109
[TBL] [Abstract][Full Text] [Related]
3. HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.
Crooks J; Mroz MM; VanDyke M; McGrath A; Schuler C; McCanlies EC; Virji MA; Rosenman KD; Rossman M; Rice C; Monos D; Fingerlin TE; Maier LA
Occup Environ Med; 2022 Feb; 79(2):120-126. PubMed ID: 34535537
[TBL] [Abstract][Full Text] [Related]
4. Lack of an Exposure Response and Interaction With HLA-DPβ1 and DRβ1 Polymorphisms in the Development of Beryllium Toxicity in a High Beryllium Exposure Cohort.
Widyaningsih V; Rosenman K; Reilly MJ; Wang L; Pathak DR; Gardiner JC; Rice C; Monos D; Rossman M
J Occup Environ Med; 2020 Jan; 62(1):64-73. PubMed ID: 31743304
[TBL] [Abstract][Full Text] [Related]
5. Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove.
Silveira LJ; McCanlies EC; Fingerlin TE; Van Dyke MV; Mroz MM; Strand M; Fontenot AP; Bowerman N; Dabelea DM; Schuler CR; Weston A; Maier LA
J Immunol; 2012 Oct; 189(8):4014-23. PubMed ID: 22972925
[TBL] [Abstract][Full Text] [Related]
6. Research to Practice Implications of High-Risk Genotypes for Beryllium Sensitization and Disease.
Kreiss K; Fechter-Leggett ED; McCanlies EC; Schuler CR; Weston A
J Occup Environ Med; 2016 Sep; 58(9):855-60. PubMed ID: 27414009
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review.
McCleskey TM; Buchner V; Field RW; Scott BL
Rev Environ Health; 2009; 24(2):75-115. PubMed ID: 19658317
[TBL] [Abstract][Full Text] [Related]
8. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.
Maier LA; McGrath DS; Sato H; Lympany P; Welsh K; Du Bois R; Silveira L; Fontenot AP; Sawyer RT; Wilcox E; Newman LS
J Immunol; 2003 Dec; 171(12):6910-8. PubMed ID: 14662898
[TBL] [Abstract][Full Text] [Related]
9. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
[TBL] [Abstract][Full Text] [Related]
10. Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease.
Snyder JA; Demchuk E; McCanlies EC; Schuler CR; Kreiss K; Andrew ME; Frye BL; Ensey JS; Stanton ML; Weston A
J R Soc Interface; 2008 Jul; 5(24):749-58. PubMed ID: 17956852
[TBL] [Abstract][Full Text] [Related]
11. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.
Balmes JR; Abraham JL; Dweik RA; Fireman E; Fontenot AP; Maier LA; Muller-Quernheim J; Ostiguy G; Pepper LD; Saltini C; Schuler CR; Takaro TK; Wambach PF;
Am J Respir Crit Care Med; 2014 Nov; 190(10):e34-59. PubMed ID: 25398119
[TBL] [Abstract][Full Text] [Related]
12. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
[TBL] [Abstract][Full Text] [Related]
13. Genetic susceptibility to beryllium: a case-referent study of men and women of working age with sarcoidosis or other chronic lung disease.
Cherry N; Beach J; Burstyn I; Parboosingh J; Schouchen J; Senthilselvan A; Svenson L; Tamminga J; Yiannakoulias N
Occup Environ Med; 2015 Jan; 72(1):21-7. PubMed ID: 25305207
[TBL] [Abstract][Full Text] [Related]
14. Risk of beryllium sensitization in a low-exposed former nuclear weapons cohort from the Cold War era.
Mikulski MA; Leonard SA; Sanderson WT; Hartley PG; Sprince NL; Fuortes LJ
Am J Ind Med; 2011 Mar; 54(3):194-204. PubMed ID: 21298695
[TBL] [Abstract][Full Text] [Related]
15. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals.
Sato H; Spagnolo P; Silveira L; Welsh KI; du Bois RM; Newman LS; Maier LA
Tissue Antigens; 2007 Dec; 70(6):480-6. PubMed ID: 17927685
[TBL] [Abstract][Full Text] [Related]
16. Beryllium: a paradigm for occupational lung disease and its prevention.
Kreiss K
Occup Environ Med; 2011 Nov; 68(11):787-8. PubMed ID: 21984591
[No Abstract] [Full Text] [Related]
17. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.
Richeldi L; Sorrentino R; Saltini C
Science; 1993 Oct; 262(5131):242-4. PubMed ID: 8105536
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of FCGR3A gene in chronic beryllium disease.
Liu B; Maier LA; Hamzeh N; MacPhail K; Mroz MM; Liu H; Li L
Genes Immun; 2019 Jul; 20(6):493-499. PubMed ID: 30245507
[TBL] [Abstract][Full Text] [Related]
19. Beryllium disease among construction trade workers at Department of Energy nuclear sites: A follow-up.
Cloeren M; Dement J; Gaitens J; Hines S; Diaz L; Tembunde Y; Cranford K; Shorter J; Mosier T; Ringen K;
Am J Ind Med; 2022 Sep; 65(9):708-720. PubMed ID: 35833586
[TBL] [Abstract][Full Text] [Related]
20. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction.
Virji MA; Park JY; Stefaniak AB; Stanton ML; Day GA; Kent MS; Kreiss K; Schuler CR
Scand J Work Environ Health; 2012 May; 38(3):247-58. PubMed ID: 21850365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
